U.S. Markets closed

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
122.00+2.35 (+1.96%)
At close: 4:00PM EST

122.00 0.00 (0.00%)
After hours: 4:57PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close119.65
Open120.00
Bid122.03 x 800
Ask122.15 x 800
Day's Range119.46 - 122.33
52 Week Range55.90 - 123.02
Volume502,739
Avg. Volume1,021,671
Market Cap12.197B
Beta (5Y Monthly)0.57
PE Ratio (TTM)N/A
EPS (TTM)-1.93
Earnings DateFeb 22, 2021 - Feb 26, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est128.89
  • Got $3,000? 3 Growth Stocks to Buy That Could Skyrocket
    Motley Fool

    Got $3,000? 3 Growth Stocks to Buy That Could Skyrocket

    You hope that every single stock you buy goes up. Otherwise, you wouldn't buy the stocks in the first place. Predicting whether they'll actually appreciate in value and by how much is just guesswork.

  • Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering
    Business Wire

    Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering

    Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The issuance and sale of the notes are scheduled to settle on November 19, 2020, subject to customary closing conditions. Guardant Health also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date notes are first issued, up to an additional $150,000,000 principal amount of notes.

  • Why Guardant Health Tumbled by Over 10% on Monday
    Motley Fool

    Why Guardant Health Tumbled by Over 10% on Monday

    Despite the roaring bull market on Monday, shares of cancer diagnostics specialist Guardant Health (NASDAQ: GH) fell dramatically. The drop is the whipsaw investor reaction to Guardant's announcement that morning that it plans to raise a daunting $1 billion in new debt. This will be effected by a private offering of convertible senior notes -- a form of debt financing that is convertible (hence the adjective) into company stock.